142 related articles for article (PubMed ID: 32243803)
1. Plasticity in Motion: Shape-Shifting Lgr5
Ganesh K
Cell Stem Cell; 2020 Apr; 26(4):469-471. PubMed ID: 32243803
[TBL] [Abstract][Full Text] [Related]
2. Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer.
Fumagalli A; Oost KC; Kester L; Morgner J; Bornes L; Bruens L; Spaargaren L; Azkanaz M; Schelfhorst T; Beerling E; Heinz MC; Postrach D; Seinstra D; Sieuwerts AM; Martens JWM; van der Elst S; van Baalen M; Bhowmick D; Vrisekoop N; Ellenbroek SIJ; Suijkerbuijk SJE; Snippert HJ; van Rheenen J
Cell Stem Cell; 2020 Apr; 26(4):569-578.e7. PubMed ID: 32169167
[TBL] [Abstract][Full Text] [Related]
3. [Expression of stem cell markers CD44 and Lgr5 in colorectal cancer and its relationship with lymph node and liver metastasis].
Wang XF; Zhang XL; Xu LP; Shi GG; Zheng HY; Sun BC
Zhonghua Yi Xue Za Zhi; 2018 Sep; 98(36):2899-2904. PubMed ID: 30293346
[No Abstract] [Full Text] [Related]
4. Expression of the adult intestinal stem cell marker Lgr5 in the metastatic cascade of colorectal cancer.
Kleist B; Xu L; Li G; Kersten C
Int J Clin Exp Pathol; 2011 Apr; 4(4):327-35. PubMed ID: 21577318
[TBL] [Abstract][Full Text] [Related]
5. GPR56 Drives Colorectal Tumor Growth and Promotes Drug Resistance through Upregulation of MDR1 Expression via a RhoA-Mediated Mechanism.
Zhang S; Chatterjee T; Godoy C; Wu L; Liu QJ; Carmon KS
Mol Cancer Res; 2019 Nov; 17(11):2196-2207. PubMed ID: 31444231
[TBL] [Abstract][Full Text] [Related]
6. Lgr5 is a potential marker of colorectal carcinoma stem cells that correlates with patient survival.
Wu XS; Xi HQ; Chen L
World J Surg Oncol; 2012 Nov; 10():244. PubMed ID: 23153436
[TBL] [Abstract][Full Text] [Related]
7. Intestinal stem cell marker LGR5 expression during gastric carcinogenesis.
Zheng ZX; Sun Y; Bu ZD; Zhang LH; Li ZY; Wu AW; Wu XJ; Wang XH; Cheng XJ; Xing XF; Du H; Ji JF
World J Gastroenterol; 2013 Dec; 19(46):8714-21. PubMed ID: 24379591
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.
Mirzaei A; Tavoosidana G; Modarressi MH; Rad AA; Fazeli MS; Shirkoohi R; Tavakoli-Yaraki M; Madjd Z
Tumour Biol; 2015 Jun; 36(6):4801-10. PubMed ID: 25631749
[TBL] [Abstract][Full Text] [Related]
9. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the adenocarcinoma-associated gene AGR2 and the intestinal stem cell marker LGR5 as biomarkers in colorectal cancer.
Valladares-Ayerbes M; Blanco-Calvo M; Reboredo M; Lorenzo-Patiño MJ; Iglesias-Díaz P; Haz M; Díaz-Prado S; Medina V; Santamarina I; Pértega S; Figueroa A; Antón-Aparicio LM
Int J Mol Sci; 2012; 13(4):4367-4387. PubMed ID: 22605983
[TBL] [Abstract][Full Text] [Related]
11. The Expression Analysis of Intestinal Cancer Stem Cell Marker Lgr5 in Colorectal Cancer Patients and the Correlation with Histopathological Markers.
Salehzadeh S; Hasanzad M; Kadijani AA; Akbari A
J Gastrointest Cancer; 2020 Jun; 51(2):591-599. PubMed ID: 31422541
[TBL] [Abstract][Full Text] [Related]
12. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
Sadek SA; A Rehim DM; Fatima S
Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
[TBL] [Abstract][Full Text] [Related]
13. Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal Cancer.
Su S; Hong F; Liang Y; Zhou J; Liang Y; Chen K; Wang X; Wang Z; Wang Z; Chang C; Han W; Gong W; Qin H; Jiang B; Xiong H; Peng L
PLoS One; 2015; 10(11):e0143513. PubMed ID: 26599100
[TBL] [Abstract][Full Text] [Related]
14. Role of Lgr5-positive cells in colorectal cancer.
Ding H; Wang C
Tumour Biol; 2015 Sep; 36(9):6759-64. PubMed ID: 25835970
[TBL] [Abstract][Full Text] [Related]
15. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis.
Han Y; Xue X; Jiang M; Guo X; Li P; Liu F; Yuan B; Shen Y; Guo X; Zhi Q; Zhao H
Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):267-73. PubMed ID: 25193236
[TBL] [Abstract][Full Text] [Related]
16. Non-Stem Cells Seed Colorectal Cancer Metastases and Gain Stem Traits.
Cancer Discov; 2020 May; 10(5):OF9. PubMed ID: 32198132
[TBL] [Abstract][Full Text] [Related]
17. LGR5 marks targetable tumor-initiating cells in mouse liver cancer.
Cao W; Li M; Liu J; Zhang S; Noordam L; Verstegen MMA; Wang L; Ma B; Li S; Wang W; Bolkestein M; Doukas M; Chen K; Ma Z; Bruno M; Sprengers D; Kwekkeboom J; van der Laan LJW; Smits R; Peppelenbosch MP; Pan Q
Nat Commun; 2020 Apr; 11(1):1961. PubMed ID: 32327656
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
[TBL] [Abstract][Full Text] [Related]
19. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?
Mirzaei A; Tavoosidana G; Rad AA; Rezaei F; Tavakoli-Yaraki M; Kadijani AA; Khalili E; Madjd Z
Tumour Biol; 2016 Feb; 37(2):2405-14. PubMed ID: 26383518
[TBL] [Abstract][Full Text] [Related]
20. Role of doublecortin-like kinase 1 and leucine-rich repeat-containing G-protein-coupled receptor 5 in patients with stage II/III colorectal cancer: Cancer progression and prognosis.
Kang XL; He LR; Chen YL; Wang SB
World J Gastroenterol; 2020 Nov; 26(43):6853-6866. PubMed ID: 33268966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
